Brief: Compass Therapeutics Reports First Quarter 2022 Financial Results

Compass Therapeutics

09/05/2022 13:01

May 9 (Reuters) - Compass Therapeutics Inc.  CMPX.O :
    * COMPASS THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
    * $136.4 MILLION IN CASH AND CASH EQUIVALENTS AT END OF Q1
    * ANTICIPATED CASH RUNWAY INTO SECOND HALF OF 2024
    * NET LOSS FOR Q1 ENDED MARCH 31, 2022 $0.07 PER COMMON
SHARE
    * Q1 EARNINGS PER SHARE VIEW $-0.12 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5ybSLm 
Further company coverage:  CMPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))